GlassScriptPhysician profile
Charles Christian Key
NPI 1336398734
$11,552.15
in general payments reported to CMS, 2019-2025
14 companies · $693 in 2025
The $693 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $1,328 · 2021: $498 · 2022: $3,878 · 2023: $2,749 · 2024: $1,813 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,077 · Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,076.53 |
| Food and Beverage | $1,179.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,747.15 | 2019-2025 | |
| Legacy Ortho LLC | $1,156.77 | 2022-2024 | |
| Cdc Medical LLC | $161.71 | 2020 | |
| Smith+Nephew, INC. | $153.11 | 2022 | |
| Medical Device Business Services, INC. | $84.20 | 2019-2024 | Velys |
| Stryker Corporation | $69.41 | 2021-2022 | |
| Davol INC. | $61.09 | 2023 | Arista Ah Flexitip |
| Dynasplint Systems INC. | $22.54 | 2019 | |
| Djo, LLC | $22.05 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.39 | 2025 | Exparel |
| Avanos Medical | $16.57 | 2020 | |
| Orthofix Medical, INC. | $12.77 | 2025 | Physio-Stim |
| Paragon 28, INC. | $12.29 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Key listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.